Literature DB >> 12076083

Early retinal damage in experimental diabetes: electroretinographical and morphological observations.

Q Li1, E Zemel, B Miller, I Perlman.   

Abstract

A growing body of evidence indicates that impairment of retinal function precedes the earliest signs of vascular complications. The aim of this study was to follow the development of retinopathy both functionally and morphologically in a rat model of diabetes mellitus. Diabetes was induced in rats by intravenous injection of streptozotocin (STZ). Age-matched rats raised under similar conditions served as control. The electroretinogram (ERG) was recorded in order to assess retinal function. The expression of glial fibrillary acidic protein (GFAP) in Müller cells was used as a cellular marker for retinal damage. The ERG responses of the diabetic rats were reduced in amplitude compared to the responses recorded from the control rats as early as 2 weeks after onset of diabetes. The b-wave was more affected than the a-wave. GFAP expression in the diabetic retina did not differ from that in the control retina during the first 5 weeks of diabetes. GFAP was demonstrated only in astrocytes in the vitreo-retinal border. After 6-7 weeks of diabetes, GFAP expression in the retinas of the diabetic rats was also detected in the endfeet of the Müller cells. With the progression of diabetes, GFAP expression spreads throughout the entire length of the Müller cells. In the retinas from control rats, GFAP expression was limited to astrocytes and was not detected in Müller cells even at 40 weeks of follow-up. The observations indicate that the functional integrity of retinal cells is compromised already at short time intervals after onset of experimental diabetes in rats. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076083     DOI: 10.1006/exer.2002.1170

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  93 in total

Review 1.  Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Authors:  Ido Perlman
Journal:  Doc Ophthalmol       Date:  2008-11-09       Impact factor: 2.379

2.  Diabetic eNOS-knockout mice develop accelerated retinopathy.

Authors:  Qiuhong Li; Amrisha Verma; Ping-Yang Han; Takahiko Nakagawa; Richard J Johnson; Maria B Grant; Martha Campbell-Thompson; Yagna P R Jarajapu; Bo Lei; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

3.  Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats.

Authors:  Xiaoping Yu; Zhaoxia Xu; Mantian Mi; Hongxia Xu; Jundong Zhu; Na Wei; Ka Chen; Qianyong Zhang; Kaihong Zeng; Jian Wang; Fang Chen; Yong Tang
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

Review 4.  Retinal ganglion cells in diabetes.

Authors:  Timothy S Kern; Alistair J Barber
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

5.  Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.

Authors:  Dustin R Masser; Heather D VanGuilder Starkey; Georgina V Bixler; Wendy Dunton; Sarah K Bronson; Willard M Freeman
Journal:  Exp Eye Res       Date:  2014-06-12       Impact factor: 3.467

6.  NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes.

Authors:  Qing Li; Esther Zemel; Benjamin Miller; Ido Perlman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-02       Impact factor: 3.117

7.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

8.  Functional Deficits Precede Structural Lesions in Mice With High-Fat Diet-Induced Diabetic Retinopathy.

Authors:  Rithwick Rajagopal; Gregory W Bligard; Sheng Zhang; Li Yin; Peter Lukasiewicz; Clay F Semenkovich
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

Review 9.  Neuropeptides and diabetic retinopathy.

Authors:  Robert Gábriel
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

10.  Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.

Authors:  Thomas J Giove; Monika M Deshpande; Christine S Gagen; William D Eldred
Journal:  Mol Vis       Date:  2009-11-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.